Helen K. Ellias
Director, SAB Biotherapeutics, Inc.
Companies
- SAB Biotherapeutics, Inc.Board member Nov 22, 2023 to now1
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- SAB Biotherapeutics, Inc. SABS2,857,142 shares2$7.4M at $2.60Nov 24, 2023
As of each latest filing. The line shows shares held over time.
Recent filings
- Nov 24, 2023Exercised options 2,857,142 shares of SAB Biotherapeutics, Inc.2
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2